Gabrilovich D - Search Results

1

Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.

Wang D, Yu Y, Haarberg K, Fu J, Kaosaard K, Nagaraj S, Anasetti C, Gabrilovich D, Yu XZ. Wang D, et al. Among authors: gabrilovich d. Biol Blood Marrow Transplant. 2013 May;19(5):692-702. doi: 10.1016/j.bbmt.2013.01.008. Epub 2013 Jan 30. Biol Blood Marrow Transplant. 2013. PMID: 23376089 Free PMC article.

2

Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.

Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Gabrilovich DI, et al. J Immunol. 2001 May 1;166(9):5398-406. doi: 10.4049/jimmunol.166.9.5398. J Immunol. 2001. PMID: 11313376

3

Immature myeloid cells and cancer-associated immune suppression.

Kusmartsev S, Gabrilovich DI. Kusmartsev S, et al. Cancer Immunol Immunother. 2002 Aug;51(6):293-8. doi: 10.1007/s00262-002-0280-8. Epub 2002 Apr 24. Cancer Immunol Immunother. 2002. PMID: 12111117 Free PMC article. Review.

4

H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors.

Gabrilovich DI, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP, Skoultchi AI. Gabrilovich DI, et al. J Leukoc Biol. 2002 Aug;72(2):285-96. J Leukoc Biol. 2002. PMID: 12149419

5

Notch signaling is necessary but not sufficient for differentiation of dendritic cells.

Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Cheng P, et al. Among authors: gabrilovich d. Blood. 2003 Dec 1;102(12):3980-8. doi: 10.1182/blood-2003-04-1034. Epub 2003 Aug 7. Blood. 2003. PMID: 12907456 Free article.

6

All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.

Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. Kusmartsev S, et al. Among authors: gabrilovich d. Cancer Res. 2003 Aug 1;63(15):4441-9. Cancer Res. 2003. PMID: 12907617

7

Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines.

Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Nefedova Y, et al. Blood. 2004 May 1;103(9):3503-10. doi: 10.1182/blood-2003-07-2340. Epub 2003 Dec 11. Blood. 2004. PMID: 14670925 Free article.

8

Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer.

Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Nefedova Y, et al. Among authors: gabrilovich d. J Immunol. 2004 Jan 1;172(1):464-74. doi: 10.4049/jimmunol.172.1.464. J Immunol. 2004. PMID: 14688356

9

Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.

Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Kusmartsev S, et al. Among authors: gabrilovich di. J Immunol. 2004 Jan 15;172(2):989-99. doi: 10.4049/jimmunol.172.2.989. J Immunol. 2004. PMID: 14707072

10

Role of immature myeloid cells in mechanisms of immune evasion in cancer.

Kusmartsev S, Gabrilovich DI. Kusmartsev S, et al. Cancer Immunol Immunother. 2006 Mar;55(3):237-45. doi: 10.1007/s00262-005-0048-z. Epub 2005 Jul 27. Cancer Immunol Immunother. 2006. PMID: 16047143 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

280 results

Search Page

Filters